Report Detail
Global (United States, European Union and China) Seasonal Influenza Vaccine Market Research Report 2019-2025
- RnM3352340 |
- 03 July, 2020 |
- Global |
- 147 Pages |
- QYResearch |
- Pharma & Healthcare
Seasonal Influenza Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Seasonal Influenza Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Seasonal Influenza Vaccine market is segmented into
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Other
Segment by Application, the Seasonal Influenza Vaccine market is segmented into
Children
Adults
Elderly
Pregnancy
Regional and Country-level Analysis
The Seasonal Influenza Vaccine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Seasonal Influenza Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Seasonal Influenza Vaccine Market Share Analysis
Seasonal Influenza Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Seasonal Influenza Vaccine business, the date to enter into the Seasonal Influenza Vaccine market, Seasonal Influenza Vaccine product introduction, recent developments, etc.
The major vendors covered:
GSK
Sinovac
Changsheng
CCBIO
Aleph Biomedical
Sanofi
Lanzhou Institute Of Biological Product
Siobp
Hualan Bio
Tianyuan Bio-Pharma
Vaxtec
Hissen
Abbott
Novartis
Tasly&Jenner
Tiantan
1 Study Coverage
- 1.1 Seasonal Influenza Vaccine Product Introduction
- 1.2 Market Segments
- 1.3 Key Seasonal Influenza Vaccine Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Seasonal Influenza Vaccine Market Size Growth Rate by Type
- 1.4.2 Trivalent Influenza Vaccine
- 1.4.3 Quadrivalent Influenza Vaccine
- 1.4.4 Other
- 1.5 Market by Application
- 1.5.1 Global Seasonal Influenza Vaccine Market Size Growth Rate by Application
- 1.5.2 Children
- 1.5.3 Adults
- 1.5.4 Elderly
- 1.5.5 Pregnancy
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Seasonal Influenza Vaccine Market Size, Estimates and Forecasts
- 2.1.1 Global Seasonal Influenza Vaccine Revenue 2015-2026
- 2.1.2 Global Seasonal Influenza Vaccine Sales 2015-2026
- 2.2 Global Seasonal Influenza Vaccine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Seasonal Influenza Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Seasonal Influenza Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Seasonal Influenza Vaccine Competitor Landscape by Players
- 3.1 Seasonal Influenza Vaccine Sales by Manufacturers
- 3.1.1 Seasonal Influenza Vaccine Sales by Manufacturers (2015-2020)
- 3.1.2 Seasonal Influenza Vaccine Sales Market Share by Manufacturers (2015-2020)
- 3.2 Seasonal Influenza Vaccine Revenue by Manufacturers
- 3.2.1 Seasonal Influenza Vaccine Revenue by Manufacturers (2015-2020)
- 3.2.2 Seasonal Influenza Vaccine Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Seasonal Influenza Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Seasonal Influenza Vaccine Revenue in 2019
- 3.2.5 Global Seasonal Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Seasonal Influenza Vaccine Price by Manufacturers
- 3.4 Seasonal Influenza Vaccine Manufacturing Base Distribution, Product Types
- 3.4.1 Seasonal Influenza Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Seasonal Influenza Vaccine Product Type
- 3.4.3 Date of International Manufacturers Enter into Seasonal Influenza Vaccine Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Seasonal Influenza Vaccine Market Size by Type (2015-2020)
- 4.1.1 Global Seasonal Influenza Vaccine Sales by Type (2015-2020)
- 4.1.2 Global Seasonal Influenza Vaccine Revenue by Type (2015-2020)
- 4.1.3 Seasonal Influenza Vaccine Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Seasonal Influenza Vaccine Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Seasonal Influenza Vaccine Sales Forecast by Type (2021-2026)
- 4.2.2 Global Seasonal Influenza Vaccine Revenue Forecast by Type (2021-2026)
- 4.2.3 Seasonal Influenza Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Seasonal Influenza Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Seasonal Influenza Vaccine Market Size by Application (2015-2020)
- 5.1.1 Global Seasonal Influenza Vaccine Sales by Application (2015-2020)
- 5.1.2 Global Seasonal Influenza Vaccine Revenue by Application (2015-2020)
- 5.1.3 Seasonal Influenza Vaccine Price by Application (2015-2020)
- 5.2 Seasonal Influenza Vaccine Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Seasonal Influenza Vaccine Sales Forecast by Application (2021-2026)
- 5.2.2 Global Seasonal Influenza Vaccine Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Seasonal Influenza Vaccine Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Seasonal Influenza Vaccine by Country
- 6.1.1 North America Seasonal Influenza Vaccine Sales by Country
- 6.1.2 North America Seasonal Influenza Vaccine Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Seasonal Influenza Vaccine Market Facts & Figures by Type
- 6.3 North America Seasonal Influenza Vaccine Market Facts & Figures by Application
7 Europe
- 7.1 Europe Seasonal Influenza Vaccine by Country
- 7.1.1 Europe Seasonal Influenza Vaccine Sales by Country
- 7.1.2 Europe Seasonal Influenza Vaccine Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Seasonal Influenza Vaccine Market Facts & Figures by Type
- 7.3 Europe Seasonal Influenza Vaccine Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Seasonal Influenza Vaccine by Region
- 8.1.1 Asia Pacific Seasonal Influenza Vaccine Sales by Region
- 8.1.2 Asia Pacific Seasonal Influenza Vaccine Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Seasonal Influenza Vaccine Market Facts & Figures by Type
- 8.3 Asia Pacific Seasonal Influenza Vaccine Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Seasonal Influenza Vaccine by Country
- 9.1.1 Latin America Seasonal Influenza Vaccine Sales by Country
- 9.1.2 Latin America Seasonal Influenza Vaccine Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Seasonal Influenza Vaccine Market Facts & Figures by Type
- 9.3 Central & South America Seasonal Influenza Vaccine Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Seasonal Influenza Vaccine by Country
- 10.1.1 Middle East and Africa Seasonal Influenza Vaccine Sales by Country
- 10.1.2 Middle East and Africa Seasonal Influenza Vaccine Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Seasonal Influenza Vaccine Market Facts & Figures by Type
- 10.3 Middle East and Africa Seasonal Influenza Vaccine Market Facts & Figures by Application
11 Company Profiles
- 11.1 GSK
- 11.1.1 GSK Corporation Information
- 11.1.2 GSK Description and Business Overview
- 11.1.3 GSK Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 GSK Seasonal Influenza Vaccine Products Offered
- 11.1.5 GSK Related Developments
- 11.2 Sinovac
- 11.2.1 Sinovac Corporation Information
- 11.2.2 Sinovac Description and Business Overview
- 11.2.3 Sinovac Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Sinovac Seasonal Influenza Vaccine Products Offered
- 11.2.5 Sinovac Related Developments
- 11.3 Changsheng
- 11.3.1 Changsheng Corporation Information
- 11.3.2 Changsheng Description and Business Overview
- 11.3.3 Changsheng Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Changsheng Seasonal Influenza Vaccine Products Offered
- 11.3.5 Changsheng Related Developments
- 11.4 CCBIO
- 11.4.1 CCBIO Corporation Information
- 11.4.2 CCBIO Description and Business Overview
- 11.4.3 CCBIO Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 CCBIO Seasonal Influenza Vaccine Products Offered
- 11.4.5 CCBIO Related Developments
- 11.5 Aleph Biomedical
- 11.5.1 Aleph Biomedical Corporation Information
- 11.5.2 Aleph Biomedical Description and Business Overview
- 11.5.3 Aleph Biomedical Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Aleph Biomedical Seasonal Influenza Vaccine Products Offered
- 11.5.5 Aleph Biomedical Related Developments
- 11.6 Sanofi
- 11.6.1 Sanofi Corporation Information
- 11.6.2 Sanofi Description and Business Overview
- 11.6.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Sanofi Seasonal Influenza Vaccine Products Offered
- 11.6.5 Sanofi Related Developments
- 11.7 Lanzhou Institute Of Biological Product
- 11.7.1 Lanzhou Institute Of Biological Product Corporation Information
- 11.7.2 Lanzhou Institute Of Biological Product Description and Business Overview
- 11.7.3 Lanzhou Institute Of Biological Product Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Lanzhou Institute Of Biological Product Seasonal Influenza Vaccine Products Offered
- 11.7.5 Lanzhou Institute Of Biological Product Related Developments
- 11.8 Siobp
- 11.8.1 Siobp Corporation Information
- 11.8.2 Siobp Description and Business Overview
- 11.8.3 Siobp Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Siobp Seasonal Influenza Vaccine Products Offered
- 11.8.5 Siobp Related Developments
- 11.9 Hualan Bio
- 11.9.1 Hualan Bio Corporation Information
- 11.9.2 Hualan Bio Description and Business Overview
- 11.9.3 Hualan Bio Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Hualan Bio Seasonal Influenza Vaccine Products Offered
- 11.9.5 Hualan Bio Related Developments
- 11.10 Tianyuan Bio-Pharma
- 11.10.1 Tianyuan Bio-Pharma Corporation Information
- 11.10.2 Tianyuan Bio-Pharma Description and Business Overview
- 11.10.3 Tianyuan Bio-Pharma Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Tianyuan Bio-Pharma Seasonal Influenza Vaccine Products Offered
- 11.10.5 Tianyuan Bio-Pharma Related Developments
- 11.1 GSK
- 11.1.1 GSK Corporation Information
- 11.1.2 GSK Description and Business Overview
- 11.1.3 GSK Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 GSK Seasonal Influenza Vaccine Products Offered
- 11.1.5 GSK Related Developments
- 11.12 Hissen
- 11.12.1 Hissen Corporation Information
- 11.12.2 Hissen Description and Business Overview
- 11.12.3 Hissen Sales, Revenue and Gross Margin (2015-2020)
- 11.12.4 Hissen Products Offered
- 11.12.5 Hissen Related Developments
- 11.13 Abbott
- 11.13.1 Abbott Corporation Information
- 11.13.2 Abbott Description and Business Overview
- 11.13.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
- 11.13.4 Abbott Products Offered
- 11.13.5 Abbott Related Developments
- 11.14 Novartis
- 11.14.1 Novartis Corporation Information
- 11.14.2 Novartis Description and Business Overview
- 11.14.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
- 11.14.4 Novartis Products Offered
- 11.14.5 Novartis Related Developments
- 11.15 Tasly&Jenner
- 11.15.1 Tasly&Jenner Corporation Information
- 11.15.2 Tasly&Jenner Description and Business Overview
- 11.15.3 Tasly&Jenner Sales, Revenue and Gross Margin (2015-2020)
- 11.15.4 Tasly&Jenner Products Offered
- 11.15.5 Tasly&Jenner Related Developments
- 11.16 Tiantan
- 11.16.1 Tiantan Corporation Information
- 11.16.2 Tiantan Description and Business Overview
- 11.16.3 Tiantan Sales, Revenue and Gross Margin (2015-2020)
- 11.16.4 Tiantan Products Offered
- 11.16.5 Tiantan Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Seasonal Influenza Vaccine Market Estimates and Projections by Region
- 12.1.1 Global Seasonal Influenza Vaccine Sales Forecast by Regions 2021-2026
- 12.1.2 Global Seasonal Influenza Vaccine Revenue Forecast by Regions 2021-2026
- 12.2 North America Seasonal Influenza Vaccine Market Size Forecast (2021-2026)
- 12.2.1 North America: Seasonal Influenza Vaccine Sales Forecast (2021-2026)
- 12.2.2 North America: Seasonal Influenza Vaccine Revenue Forecast (2021-2026)
- 12.2.3 North America: Seasonal Influenza Vaccine Market Size Forecast by Country (2021-2026)
- 12.3 Europe Seasonal Influenza Vaccine Market Size Forecast (2021-2026)
- 12.3.1 Europe: Seasonal Influenza Vaccine Sales Forecast (2021-2026)
- 12.3.2 Europe: Seasonal Influenza Vaccine Revenue Forecast (2021-2026)
- 12.3.3 Europe: Seasonal Influenza Vaccine Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Seasonal Influenza Vaccine Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Seasonal Influenza Vaccine Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Seasonal Influenza Vaccine Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Seasonal Influenza Vaccine Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Seasonal Influenza Vaccine Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Seasonal Influenza Vaccine Sales Forecast (2021-2026)
- 12.5.2 Latin America: Seasonal Influenza Vaccine Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Seasonal Influenza Vaccine Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Seasonal Influenza Vaccine Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Seasonal Influenza Vaccine Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Seasonal Influenza Vaccine Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Seasonal Influenza Vaccine Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Seasonal Influenza Vaccine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Seasonal Influenza Vaccine Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Seasonal Influenza Vaccine . Industry analysis & Market Report on Seasonal Influenza Vaccine is a syndicated market report, published as Global (United States, European Union and China) Seasonal Influenza Vaccine Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Seasonal Influenza Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
